Cholelithiasis is a pathology that can be confidently diagnosed by sonographic examination. The following case presents sonographic findings consistent with cholelithiasis in a child being treated with the antibiotic Rocephin. A follow-up preoperative sonographic examination of the gallbladder displayed no evidence of cholelithiasis. This is a classic example of Rocephin-induced "biliary pseudolithiasis."
Case Report
Cholelithiasis is an infrequent cause for intermittent bouts of abdominal pain, nausea, and diarrhea in children. In the small population of pediatric patients who do have cholelithiasis, cholecystectomy is the treatment of choice.
This case describes a pediatric patient who was experiencing intermittent symptoms consistent with gallbladder disease. Upon sonographic examination, multiple mobile echogenic foci were demonstrated within the gallbladder. A subsequent preoperative sonogram revealed no evidence of gallstones. The earlier misinterpretation was the result of concurrent ceftriaxone sodium antibiotic treatment. The importance of including medications, as well as patient signs and symptoms, as part of the patient history are discussed.
Case Presentation
A child was referred for a sonographic examination of the gallbladder, which was ordered as a preoperative follow-up examination. The clinical history indicated gallstones, documented incidentally on a renal sonographic examination performed at the same institution approximately 10 1 2 months earlier.
Prior to the sonographic examination, the previous renal study was reviewed. Although the gallbladder was not well distended, due to the nonfasting state of the patient, multiple echogenic foci were identified within the gallbladder lumen. There was shadowing demonstrated posterior to the foci (Figs. 1, 2). The common bile duct (CBD) was imaged. The diameter of the CBD was 2.3 mm ( Fig. 3) .
The child, accompanied by her mother, was then escorted to the examination room. Care was taken to explain the procedure to the child, help the child feel at ease, and determine that the child was in a fasting state. A more detailed patient history was obtained from the mother.
The child had been experiencing intermittent episodes of abdominal pain, nausea, fever, and diarrhea for almost one year. Her physician had prescribed treatment with the antibiotic ceftriaxone sodium (Rocephin) for suspected abdominal inflammation. She subsequently presented to the emergency room with abdominal pain and fever. An x-ray of her abdomen and a sonogram of her kidneys and bladder were ordered by the emergency room physician. An incidental finding on the renal sonogram was cholelithiasis. After almost a year of recurring medical treatment for these symptoms, cholecystectomy was recommended. The mother, however, was reluctant to subject her child to surgery and had requested a repeat sonographic evaluation of the gallbladder.
The sonographic examination was performed on an Acuson Sequoia sonography machine (Acuson, a Siemens Company, Mountain View, CA), using the 4C1 MHz and 6C2 MHz curved linear array transducers. Multiple images of the right upper quadrant (RUQ), with special emphasis on the gallbladder, were then obtained. The gallbladder was well demonstrated. The gallbladder wall was not thickened, and there was no evidence of gallstones (Figs. 4, 5) . The diameter of the CBD was 3.3 mm ( Fig. 6 ). No abnormalities were identified within the RUQ.
Because of the discrepancy in sonographic findings between the two examinations, the radiologist came to the examination room for real-time observation. Careful reexamination produced the same sonographic findings. The radiologist could offer no obvious explanation for the differences in findings between the two sonographic examinations. Intuitively, the sonographer consulted the 57th edition of the Physician's Desk Reference (PDR) to research the pharmaceutical antibiotic, Rocephin. The PDR indicated that sonographic abnormalities in the gallbladder of patients treated with Rocephin have been reported. Some patients also exhibit symptoms of gallbladder disease. The abnormal sonographic appearance is attributed to ceftriaxone calcium salt precipitatins and may be misinterpreted as gallstones. These findings are reversible upon discontinuation of treatment with Rocephin. 1 This information was immediately brought to the radiologist's attention. The interpreting physician's report indicated that the previously seen gallstones were not seen on the current examination. The report further stated that the patient was reported to have been on Rocephin prior to the original sonographic examination, which can sonographically mimic gallstones. Clinical correlation was suggested.
Discussion
The incidence of cholelithiasis occurring in childhood is 1.5%. Only 20% of these children will be in the age range of 6 months to 10 years. 2 Generally, three conditions cause gallstones: (1) abnormal bile composition, (2) stasis, and (3) infection. Cholelithiasis, however, in older children and adolescents may be associated with cystic fibrosis, malabsorbtion, total parenteral nutrition, liver disease, Crohn's disease, bowel resection, and hemolytic anemia. 2 Most children who are diagnosed with gallstones have other underlying conditions, such as hemolytic disease, obesity, and a family history of cholelithiasis. Few children are diagnosed with cholelithiasis of idiopathic origin.
Three significant characteristics confirm a sonographic diagnosis of cholelithiasis. Those characteristics are (1) echogenicity, (2) shadowing, and (3) gravity dependence (mobile). Because of the density differences of the stone and surrounding bile, a great deal of the sonography beam is reflected when it strikes the stone. Therefore, the stone appears very echogenic and produces posterior acoustic shadowing from reflection, attenuation, and/or refraction. However, stones less than 3 mm may not always produce shadowing. 3 Shadowing can also be produced by the Heister valves located in the neck of the gallbladder, loops of the bowel, edge refraction, or a junctional fold. 4 To differentiate a gallstone from a papilloma, polyp, or other gallbladder wall lesion, the sonographer must position the patient in an oblique, decubitus, or upright position to elicit movement of the echogenic foci to the dependant portion of the gallbladder. Typical clinical symptoms of cholelithiasis are RUQ pain, vomiting, and nausea. Postprandial fatty meal intolerance is also indicative of cholelithiasis, particularly when accompanied by RUQ pain. Sonographic examination may cause patient discomfort upon compression over the gallbladder area. This rebound tenderness is referred to as a positive Murphy's sign. Clinical lab results consistent with cholelithiasis include elevated amylase, abnormal liver function, and increased direct bilirubin blood values.
If cholelithiasis is found incidentally in a patient who is asymptomatic, cholecystectomy may not be the treatment of choice. The patient with silent symptoms may decide that cholecystectomy is not worth the discomfort, bloating, and diet change. Pain experienced with acute cholelithiasis is intermittent, possibly getting worse as time goes on but never ceasing. In the presence of acute cholecystitis and cholelithiasis, cholecystectomy is highly recommended. The laparoscopic technique has increased the rate of cholecystectomy surgery. 2 Because little information is known about longterm effects from cholelithiasis at a young age, all children diagnosed with cholelithiasis should be considered for cholecystectomy. 2 The incidence of all cholecystectomies among patients younger than age 20 is only 4%. 5 An alternative for children who are not able to tolerate surgery is lithotripsy. Lithotripsy is performed using shock waves in combination with a sonography probe. Besides lithotripsy, there are no nonsurgical approaches approved for children. 2 This case is of interest because the cholelithiasis diagnosed earlier was, if fact, biliary pseudolithiasis. The earliest reported case found in the literature dates back to 1986. 6 The term biliary pseudolithiasis was introduced in 1988, describing a study of 37 children being treated with ceftriaxone for various infections. Sixteen of those 37 children developed biliary pseudolithiasis within 4 to 22 days. All 16 cases (documented by abdominal sonography) resolved within 2 to 63 days upon completion of treatment. 7 Similar findings continue to be reported in more current literature. [8] [9] [10] Interestingly, a case study of a transient false-positive hepatobiliary scan associated with this same drug was also reported in a nuclear medicine journal. 11 The pharmaceutical ceftriaxone sodium (brand name Rocephin) is a third-generation cephalosporin drug, having few serious side effects and useful for treating a wide variety of serious infections. 12 Cephalosporins are a group of drugs described as "chemical modifications" of the antibiotic penicillin. There are three generations of cephalosporins. The antimicrobial activity of the first generation was primarily focused on grampositive bacteria. The second generation expanded to include gram-negative bacteria. The third generation of cephalosporin drugs expanded the antimicrobial activity to an even greater range of bacterial microorganisms. Rocephin is indicated for the treatment of lower respiratory tract infections, Streptococcus pneumoniae, skin and skin structure infections, urinary tract infections, pelvic inflammatory disease, meningitis, intra-abdominal infections, and surgical prophylaxis. The method of treatment is injection (intramuscular or intravenous), administered for 4 to 14 days, not exceeding 2 g per day. The drug is excreted (33%-67%) through the urine and the remainder via the bile and through the feces. 1 Rocephin has a high sodium content and calcium-binding affinity. 7, 13 In instances when cholecystectomy was performed, analysis of the gallbladder contents revealed a precipitate largely consistent with the ceftriaxone calcium salts. 14 Because Rocephin is excreted via the biliary and renal systems, adverse effects include diarrhea, elevation of alkaline phosphatase and bilirubin, and pseudomembranous colitis. 1 Cholelithiasis associated with two other pharmaceuticals has been described in the literature. Neither of these pharmaceuticals, however, was described as reversing cholelithiasis upon discontinuation of treatment.
A woman in her mid-60s with a 20-year history of rheumatoid arthritis was being treated with Sulindac, a nonsteroidal anti-inflammatory drug. This drug is also administered orally and excreted via the urine and bile. After two months on Sulindac treatment, she presented with right upperquadrant pain and elevated liver function tests. Cholelithiasis was diagnosed by sonography. Postcholecystectomy analysis of the stones revealed a precipitate of Sulindac sulfone. 15 The other drug described as being associated with cholelithiasis is cyclosporine. Cyclosporine is an immunosuppressive agent used to reduce the rate of rejection associated with organ transplant. This drug is also eliminated primarily via the bile and secondarily via the urine. The chemical makeup of these gallstones, however, was not reported to be a precipitate of the cyclosporine drug. [16] [17] [18] 
Conclusion
The incidence of ceftriaxone (Rocephin)induced pseudolithiasis has been well documented. This condition is reversible upon discontinuation of the drug, eliminating the need for surgical intervention. Cholelithiasis associated with the drugs Sulindac and cyclosporine has also been reported. This raises the question of other drug-related cholelithiasis conditions. This case exemplifies the importance of the sonographer's role in patient care. The extra time and effort taken to actively question and listen to the patient may make a significant difference in the ultimate outcome.
